 These emotional processing biases may explain the therapeutic gap.While various abnormalities have been observed in dopaminergic systems, results have been inconsistent.People with MDD have an increased reward response to dextroamphetamine compared to controls, and it has been suggested that this results from hypersensitivity of dopaminergic pathways due to natural hypoactivity.